Democratic Senator And Former Astronaut Mark Kelly Joins Colleagues Against Federal Marijuana Reform

Even though the House of Representatives approved the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, H.R. 3617 on April 1, sending it to Senate, the big cannabis battle isn’t over. Some say it has just begun.

The MORE Act, which aim removes cannabis from the federal Controlled Substances Act, allowing states to legalize cannabis, its production, and sale, free from federal interference, seems to have many opponents among politicians. 

On the other hand, the newest survey, conducted by YouGov using a nationally representative sample of 1,000 U.S. adult citizens interviewed online from April 1 to 5 – just confirmed the results from the previous year’s poll – more than 50% of the U.S. population wants to see marijuana legal on the federal level.

More precisely, 60% said yes to cannabis legalization. While Democrats are more likely to support the change, 72% of them voted for marijuana reform. Republicans are evenly split on the issue, with 46% supporting and 46% opposing it.

Just this week, U.S. Senator Mark Kelly (D-AZ) confirmed the fear that the bill doesn’t have the support of all the Democrats in the Senate. 

Kelly, a retired NASA astronaut and retired U.S. Navy captain, noted that the bill should make operations easier for cannabis businesses in states that have legalized the plant, but “stopped short of endorsing it,” writes azfamily.

 “I think in general, folks that are legally conducting business in states like Arizona should have access to the banking system, but I’ll have to look at the details,” Kelly said.

This is a clear sign that the MORE Act has slim chances of reaching President Biden’s desk, considering it needs 60 votes out of the 100-member chamber and most of the Republicans already openly spoke against it.

Senators Who Recently Opened Up Against Cannabis Reform 

When asked last week at the Capitol about the MORE Act, Sen. Rick Scott (R-Fla.) said, “Okay, I don’t support that. I’ve had family members who have had a lot of drug issues, and so I’m not going to do it,” reported CNSNews

Sen. Ted Cruz (R-Tex) replied and Sen. James Lankford (R-Okla) shared the same stance.

Even, Rep. Nancy Mace (R-SC), who is one of the leaders among GOP representatives in favor of removing cannabis from the list of federally controlled substances voted against it. Why? 

“The MORE Act forces a system on South Carolinians and other states they do not want. By comparison, my bill, the States Reform Act, removes the federal government from the equation and allows states to decide for themselves,” Mace explained as reported by The State.  

Sen. Roy Blunt (R-MO.) doesn't think the measure "would pass the Senate right now,” and Sen. Steve Daines (R-Mont.) emphasized that there are "serious drug problems in Montana," a state that legalized recreational marijuana in recent years.

A Spark Of Light 

What many cannabis enthusiasts across the U.S. say they're hoping for, and most cannabis industry experts agree upon is that medical marijuana legalization has a better chance, as does some form of cannabis banking reform. 

Republicans, in general, seem to be more interested in helping to resolve what many see as one of the biggest problems in the industry – banking. Whereas medical marijuana reform seems to be more easily acceptable to members of both parties. 

What do you think? Will we see either pass this year? 

Photo: Courtesy of Wikimedia Commons

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsPoliticsMarketsMediaGeneralazfamilyCNSNewsJames LankfordMark KellyNancy MaceRick ScottRoy BluntSteve DainesTed Cruzthe MORE ActThe State
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.